| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/25/2010 | WO2009156747A3 Assay |
| 02/25/2010 | WO2009155443A3 Method and apparatus for sequencing data samples |
| 02/25/2010 | WO2009155151A3 Functional imaging of cells optical projection tomography |
| 02/25/2010 | WO2009154966A3 Cleavable catalytic binding and detection system |
| 02/25/2010 | WO2009153142A3 Microfluidic system |
| 02/25/2010 | WO2009152607A8 Methods and kits for diagnosing neurodegenerative disease |
| 02/25/2010 | WO2009151697A3 Compositions and processes relating to human bocavirus |
| 02/25/2010 | WO2009151696A3 Accelerated molecular dynamics of proteins and other biomolecules |
| 02/25/2010 | WO2009151618A3 Methods and compositions for treating alzheimer's disease |
| 02/25/2010 | WO2009151542A3 Nicotinic acid receptor ligands |
| 02/25/2010 | WO2009151518A3 Methods and compositions for predicting development of atopic diseases |
| 02/25/2010 | WO2009150255A3 Markers for predicting response and survival in anti-egfr treated patients |
| 02/25/2010 | WO2009149359A3 Survival predictor for diffuse large b cell lymphoma |
| 02/25/2010 | WO2009147209A3 Method for and material of a shape standard |
| 02/25/2010 | WO2009146450A3 Methods for monitoring immunosuppressant drug levels, renal function, and hepatic function using small volume samples |
| 02/25/2010 | WO2009146166A3 Biotin-receptor reagents for sensitivity modulation in assays |
| 02/25/2010 | WO2009146157A3 Methods of generating florescence resonance energy transfer |
| 02/25/2010 | WO2009145815A3 Biomarkers of ovarian cancer |
| 02/25/2010 | WO2009143816A4 Method for isolating cells and disease vectors from bodily fluids |
| 02/25/2010 | WO2009143493A3 MODULATORS OF TNFα-DEPENDENT SIGNALING PATHWAYS AND USES THEREOF |
| 02/25/2010 | WO2009143365A3 Compositions and methods of treatment using modulators of motoneuron diseases |
| 02/25/2010 | WO2009143080A3 Methods, devices, kits and compositions for detecting roundworm |
| 02/25/2010 | WO2009140198A3 Pathogen detection and screening |
| 02/25/2010 | WO2009137763A3 Methods and compositions for the display of polypeptides on the pili of gram-positive bacteria |
| 02/25/2010 | WO2009137632A3 Hiv immunogen and method of making and using same |
| 02/25/2010 | WO2009135152A3 Arrayed detector system for measurement of influenza immune response |
| 02/25/2010 | WO2009134944A3 Methods of determining the health status of an individual |
| 02/25/2010 | WO2009126310A3 Methods for identification and use of agents targeting cancer stem cells |
| 02/25/2010 | WO2009112905A3 Real-time digital image processing architecture |
| 02/25/2010 | WO2009058765A3 Apparatus for dispensing and analysing test strips |
| 02/25/2010 | WO2009016181A3 Optical imaging agents |
| 02/25/2010 | WO2009013621A3 Antibodies and sirna against growth hormone, prolactin and proliferin for use in the treatment of tumors and endometriosis |
| 02/25/2010 | WO2009012095A8 Inspection apparatus and method using penetrating radiation |
| 02/25/2010 | WO2008149364A3 Methods for diagnosing hypersensitivity reactions |
| 02/25/2010 | WO2008132753A3 Methods and kits for detecting fetal cells in the maternal blood |
| 02/25/2010 | WO2008093343A3 Schizophrenia associated genes and markers |
| 02/25/2010 | US20100050281 Identification of Genes and Their Products Which Promote Hybrid Vigour or Hybrid Debility and Uses Thereof |
| 02/25/2010 | US20100050278 Application of Actin-Binding Protein to Disease Associated With Cell Motility |
| 02/25/2010 | US20100050277 Knockout animal exhibiting anxiety-like behavior |
| 02/25/2010 | US20100049685 Pattern Discovery Techniques for Determining Maximal Irredundant and Redundant Motifs |
| 02/25/2010 | US20100049672 Methods for Reducing Sample Size of Clinical Trials |
| 02/25/2010 | US20100049449 Pattern Discovery Techniques for Determining Maximal Irredundant and Redundant Motifs |
| 02/25/2010 | US20100049444 Calibration surface method for determination of analyte ratios |
| 02/25/2010 | US20100049016 Noninvasive Transdermal Systems for Detecting an Analyte in a Biological Fluid and Methods |
| 02/25/2010 | US20100049015 Specificity of analyte detection in etalons |
| 02/25/2010 | US20100048944 Interactions of hedgehog and liver x receptor signaling pathways |
| 02/25/2010 | US20100048890 Conjugated small molecules |
| 02/25/2010 | US20100048877 Novel multivalent immunoglobulins |
| 02/25/2010 | US20100048714 Methods and Compositions Related to Inhibition of Ceramide Synthesis |
| 02/25/2010 | US20100048680 Alpha-1-Antitrypsin Variants and Uses Thereof |
| 02/25/2010 | US20100048676 Non-androgen dependent roles for androgen receptor in liver cancer |
| 02/25/2010 | US20100048650 Two pore channels as a therapeutic target to protect against myocardial ischemia and as an adjuvant in cardiac surgery |
| 02/25/2010 | US20100048626 Aryl Substituted Pyridines and the Use Thereof |
| 02/25/2010 | US20100048525 Androgen treatment in females |
| 02/25/2010 | US20100048501 Phosphorylated A2A Receptor Agonists |
| 02/25/2010 | US20100048499 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane |
| 02/25/2010 | US20100048488 Immunomodulatory peptides |
| 02/25/2010 | US20100048486 Use of Soluble Fgl2 As An Immunosuppressant |
| 02/25/2010 | US20100048485 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate |
| 02/25/2010 | US20100048466 Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance |
| 02/25/2010 | US20100048458 Tribonectins |
| 02/25/2010 | US20100048450 Sumoylation Control Agent and Uses Thereof |
| 02/25/2010 | US20100048415 Method for the detection of interferon-associated angiostatic tumorstages in colorectal carcinoma |
| 02/25/2010 | US20100048412 Detection of protease and protease activity using a single nanoscrescent sers probe |
| 02/25/2010 | US20100048407 Method for detection of human immunodeficiency virus |
| 02/25/2010 | US20100047928 Target substance detection element, target substance detection method, and method for producing target substance detection element |
| 02/25/2010 | US20100047927 Kit for measurement of termite insecticide active ingredient by immunoassay method |
| 02/25/2010 | US20100047926 Hybridization chain reaction |
| 02/25/2010 | US20100047925 Sequential analysis of biological samples |
| 02/25/2010 | US20100047924 Stable nanoreporters |
| 02/25/2010 | US20100047923 Two helix binders |
| 02/25/2010 | US20100047922 Turbidimetric immunoassay for assessing human cystatin c |
| 02/25/2010 | US20100047919 Biosensor device and method for detecting molecules in an analyte |
| 02/25/2010 | US20100047917 Method for assaying sulfur and apparatus therefor |
| 02/25/2010 | US20100047915 Identifying patients at risk for life threatening arrhythmias |
| 02/25/2010 | US20100047914 Agent detection and/or quantitation in a biological fluid |
| 02/25/2010 | US20100047913 Colloidal Gold Single Reagent Quantitative Protein Assay |
| 02/25/2010 | US20100047901 System and method for electronic sensing of biomolecules |
| 02/25/2010 | US20100047896 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |
| 02/25/2010 | US20100047895 Methods for purification of bacterial cells and cell components |
| 02/25/2010 | US20100047851 Methods and compositions for the detection of microbial contaminants |
| 02/25/2010 | US20100047849 Determination of testosterone by mass spectrometry |
| 02/25/2010 | US20100047847 Methods for diagnosing ovarian cancer |
| 02/25/2010 | US20100047846 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 02/25/2010 | US20100047844 Diagnostic marker for fabry disease |
| 02/25/2010 | US20100047840 Polypeptide markers for the diagnosis of bladder cancer |
| 02/25/2010 | US20100047837 Method for the early detection of renal injury |
| 02/25/2010 | US20100047835 Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart failure |
| 02/25/2010 | US20100047832 Assessment of Patients with Sepsis to Determine a Requirement for Therapeutic Intervention with an Anti-Inflammatory and/or Anticoagulatory Agent |
| 02/25/2010 | US20100047831 Diagnosis of anthrax infection by detection of capsular antigen in urine |
| 02/25/2010 | US20100047830 Compositions and methods for detecting cancers in a subject |
| 02/25/2010 | US20100047829 Activated her3 as a marker for predicting therapeutic efficacy |
| 02/25/2010 | US20100047828 Solid-phase detection of terminal monosaccharides cleaved from glycosylated substrates |
| 02/25/2010 | US20100047827 Novel specific cell binders |
| 02/25/2010 | US20100047826 Cell Into Which Protein, Which Can Serve as Polymerization Nucleus of Protein Polymer, or Polymer Thereof Is Introduced, and Method for Production of The Cell |
| 02/25/2010 | US20100047825 Immunoassay reagents and methods of use thereof |
| 02/25/2010 | US20100047824 Citrus fruit peeling process |
| 02/25/2010 | US20100047823 Polypeptides |
| 02/25/2010 | US20100047822 Timp-4 as a biomarker for the diagnosis of cardiac insufficiency |
| 02/25/2010 | US20100047821 Crown ether derivatives |